Cortexyme competitorsClear all

Cortexyme's top competitors include Alector, Aimmune Therapeutics and Portola Pharmaceuticals.
Cortexyme
Cortexyme
Cortexyme is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders.
Alector
Alector
Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.
Aimmune Therapeutics
Aimmune Therapeutics
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
Portola Pharmaceuticals
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company.
Founding Date
Founding Date
2012
Founding Date
2013
Founding Date
2011
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
South San Francisco, US HQ
Milpitas, US
Locations
Brisbane, US HQ
München, DE
Dublin, IE
London, GB
Durham, US
Locations
South San Francisco, US HQ
Krailling, DE
Amsterdam, NL
Employees
Employees
2321% increase
Employees
1264% increase
Employees
2755% increase
Employees
32429% increase
Valuation ($)
Valuation ($)
961.9 m
Valuation ($)
1.3 b
Valuation ($)
2.3 b
Valuation ($)
1.4 b
Twitter followers
Twitter followers
311
Twitter followers
N/A
Twitter followers
1.6 k
Twitter followers
951
Alexa Website Rank
Alexa Website Rank
427855
Alexa Website Rank
302916
Alexa Website Rank
193253
Alexa Website Rank
251077
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.3
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$21.2m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$116.6m (FY, 2019)
Net income
Net income
($37m) (FY, 2019)
Net income
($105.4m) (FY, 2019)
Net income
($248.5m) (FY, 2019)
Net income
($290.7m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 100m
Total funding raised
$ 194.5m
Total funding raised
$ 145m
Total funding raised
$ 295.1m
For sources of this data, please see the company profile

View company profiles

Alector
HQ
South San Francisco, US
Employees
126↑ 4% increase

Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.

View company
Aimmune Therapeutics
HQ
Brisbane, US
Employees
275↑ 5% increase

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.

View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase

Portola Pharmaceuticals is a biopharmaceutical company.

View company